# Tuesday, 17 August 2010
Most of the time, the FDA is a valued oversight organization protecting all of us and assuring that new drugs and devices are safe and useful. Is there a point where it begins to act like big brother, attempting to limit our personal choice? Where is the line between these two extremes?
Tuesday, 17 August 2010 14:28:34 (Eastern Daylight Time, UTC-04:00)  #    Disclaimer  |  Comments [0]  |  Trackback
strong argument was made for studying the relative effectiveness of screening colonoscopy and sigmoidoscopy. Based on a review in JAMA of three studies conducted outside the US that showed no difference in colon cancer mortality or incidence when the two procedures were compared, the Times proposed a US study to answer this question.
Tuesday, 17 August 2010 12:31:39 (Eastern Daylight Time, UTC-04:00)  #    Disclaimer  |  Comments [0]  |  Trackback
# Tuesday, 27 July 2010

A strategic online resource for internal compliance programs. We help pharmaceutical and medical device clients map the regulatory landscape for effective sales and marketing.

Tuesday, 27 July 2010 14:37:24 (Eastern Daylight Time, UTC-04:00)  #    Disclaimer  |  Comments [0]  |  Trackback
# Friday, 23 July 2010

In response to R. Pete Vanderveen's kind offer ("How to Care for 30 Million More Patients," op-ed July 19): Thanks but no thanks.

Pharmacy is an ancient art that used to be practiced by physicians. It was gradually surrendered, largely due to the obvious conflict of interest involved in prescribing, then selling, various remedies.

I have only respect for pharmacists, and they are an indispensable part of the team. They can, and do, pick up potential drug interactions. Most physicians appreciate updates on what our patients are actually taking.

However, pharmacists do not have a Hippocratic obligation to the patient. Allowing pharmacists to practice medicine would likely create more problems than it would solve. The need for doctors to stay in contact with dozens of pharmacists would add considerably to our workload.


Friday, 23 July 2010 15:43:39 (Eastern Daylight Time, UTC-04:00)  #    Disclaimer  |  Comments [0]  |  Trackback
# Thursday, 15 July 2010
Thursday, 15 July 2010 17:25:35 (Eastern Daylight Time, UTC-04:00)  #    Disclaimer  |  Comments [0]  |  Trackback
# Monday, 08 February 2010

In a recent series of articles in the NY Times, Walt Bogdanich uncovered an alarming series of radiation treatment errors associated with implementation of new computerized treatment technologies such as IMRT. Based on this article, reporting hundreds of cases, some of them fatal, it appears that a variety of causes are associated with errors, including inadequate training of physicists and radiation therapists, difficulty physically validating computer-generated treatment plans, over-reliance on reliability of computer technology and inadequacy of traditional radiation oncology quality assurance approaches in the era of new technologies.

Monday, 08 February 2010 11:42:04 (Eastern Standard Time, UTC-05:00)  #    Disclaimer  |  Comments [0]  |  Trackback
# Wednesday, 25 November 2009
EML4-ALK translocation in cancer
Wednesday, 25 November 2009 15:19:52 (Eastern Standard Time, UTC-05:00)  #    Disclaimer  |  Comments [0]  |  Trackback